{"title":"Cerebral ammonia metabolism in normal and hyperammonemic rats.","authors":"A J Cooper, J C Lai","doi":"10.1007/BF02833601","DOIUrl":null,"url":null,"abstract":"<p><p>Brain ammonia is generated from many enzymatic reactions, including glutaminase, glutamate dehydrogenase, and the purine nucleotide cycle. In contrast, the brain possesses only one major enzyme for the removal of exogenous ammonia, i.e., glutamine synthetase. Thus, following administration of [13N]ammonia to rats [via either the carotid artery or cerebrospinal fluid (csf)], most metabolized label was in glutamine (amide) and little was in glutamate (plus aspartate). Since blood-and csf-borne ammonia are converted to glutamine largely, if not entirely, in the astrocytes, it is not possible from these types of experiments to predict with certainty the metabolic fate of the bulk of endogenously produced ammonia. By comparing the specific activity of L-[13N]glutamate to that of L-[amine-13N]glutamine following intracarotid [13N]ammonia administration it was concluded that metabolic compartmentation is no longer intact in the brains of rats treated with the glutamine synthetase inhibitor L-methionine-SR-sulfoximine (MSO) and that blood and brain ammonia pools mix in such animals. In MSO-treated animals, recovery of label in brain was low (approximately 20% of controls), and of the label remaining, a prominent portion was in glutamine (amide) (despite an 87% decrease in brain glutamine synthetase activity). These data are consistent with the hypothesis that glutamine synthetase is the major enzyme for metabolism of endogenously--as well as exogenously--produced ammonia. The rate of turnover of blood-derived ammonia to glutamine in normal rat brain is extremely rapid (t1/2 less than or equal to 3 s), but is slowed in the brains of chronically (12-14-wk portacaval-shunted) or acutely (urease-treated) hyperammonemic rats (t1/2 less than or equal to 10 s). The slowed turnover rate may be caused by an increased astrocytic ammonia, decreased glutamine synthetase activity, or both. In the hyperammonemic rat brain, glutamine synthetase is still the only important enzyme for the removal of blood-borne ammonia. Hyperammonemia causes an increase in brain lactate/pyruvate ratios and decreases in brain glutamate and brainstem ATP, consistent with an interference with the malate-aspartate shuttle. In vitro, pathological levels of ammonia also inhibit brain alpha-ketoglutarate dehydrogenase complex and, less strongly, pyruvate dehydrogenase complex. The rat brain does not adapt to prolonged hyperammonemia by increasing its glutamine synthetase activity.(ABSTRACT TRUNCATED AT 400 WORDS)</p>","PeriodicalId":77753,"journal":{"name":"Neurochemical pathology","volume":"6 1-2","pages":"67-95"},"PeriodicalIF":0.0000,"publicationDate":"1987-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02833601","citationCount":"80","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurochemical pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF02833601","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 80
Abstract
Brain ammonia is generated from many enzymatic reactions, including glutaminase, glutamate dehydrogenase, and the purine nucleotide cycle. In contrast, the brain possesses only one major enzyme for the removal of exogenous ammonia, i.e., glutamine synthetase. Thus, following administration of [13N]ammonia to rats [via either the carotid artery or cerebrospinal fluid (csf)], most metabolized label was in glutamine (amide) and little was in glutamate (plus aspartate). Since blood-and csf-borne ammonia are converted to glutamine largely, if not entirely, in the astrocytes, it is not possible from these types of experiments to predict with certainty the metabolic fate of the bulk of endogenously produced ammonia. By comparing the specific activity of L-[13N]glutamate to that of L-[amine-13N]glutamine following intracarotid [13N]ammonia administration it was concluded that metabolic compartmentation is no longer intact in the brains of rats treated with the glutamine synthetase inhibitor L-methionine-SR-sulfoximine (MSO) and that blood and brain ammonia pools mix in such animals. In MSO-treated animals, recovery of label in brain was low (approximately 20% of controls), and of the label remaining, a prominent portion was in glutamine (amide) (despite an 87% decrease in brain glutamine synthetase activity). These data are consistent with the hypothesis that glutamine synthetase is the major enzyme for metabolism of endogenously--as well as exogenously--produced ammonia. The rate of turnover of blood-derived ammonia to glutamine in normal rat brain is extremely rapid (t1/2 less than or equal to 3 s), but is slowed in the brains of chronically (12-14-wk portacaval-shunted) or acutely (urease-treated) hyperammonemic rats (t1/2 less than or equal to 10 s). The slowed turnover rate may be caused by an increased astrocytic ammonia, decreased glutamine synthetase activity, or both. In the hyperammonemic rat brain, glutamine synthetase is still the only important enzyme for the removal of blood-borne ammonia. Hyperammonemia causes an increase in brain lactate/pyruvate ratios and decreases in brain glutamate and brainstem ATP, consistent with an interference with the malate-aspartate shuttle. In vitro, pathological levels of ammonia also inhibit brain alpha-ketoglutarate dehydrogenase complex and, less strongly, pyruvate dehydrogenase complex. The rat brain does not adapt to prolonged hyperammonemia by increasing its glutamine synthetase activity.(ABSTRACT TRUNCATED AT 400 WORDS)
脑氨是由许多酶促反应产生的,包括谷氨酰胺酶、谷氨酸脱氢酶和嘌呤核苷酸循环。相比之下,大脑只有一种主要的酶来去除外源氨,即谷氨酰胺合成酶。因此,在给大鼠服用[13N]氨后[通过颈动脉或脑脊液],大部分代谢的标签是谷氨酰胺(酰胺),谷氨酸(加上天冬氨酸)很少。由于血液和csf传播的氨在星形胶质细胞中大部分(如果不是全部)转化为谷氨酰胺,因此不可能从这些类型的实验中确定地预测大部分内源性氨的代谢命运。通过比较颈动脉内给予[13N]氨后L-[13N]谷氨酸和L-[胺-13N]谷氨酰胺的比活性,我们得出结论:在使用谷氨酰胺合成酶抑制剂L-蛋氨酸- sr -亚砜亚胺(MSO)治疗的大鼠大脑中,代谢区隔不再完整,血液和脑氨池混合。在mso治疗的动物中,大脑中标签的恢复很低(约为对照组的20%),并且在剩余的标签中,谷氨酰胺(酰胺)的比例很大(尽管脑谷氨酰胺合成酶活性降低了87%)。这些数据与谷氨酰胺合成酶是内源性和外源性氨代谢的主要酶的假设是一致的。正常大鼠脑中血源性氨转化为谷氨酰胺的速度非常快(t1/2小于或等于3秒),但在慢性(12-14周门静脉分流)或急性(脲酶处理)高氨血症大鼠脑中(t1/2小于或等于10秒),转化速度减慢可能是由于星形细胞氨增加,谷氨酰胺合成酶活性降低,或两者兼有。在高氨血症的大鼠脑中,谷氨酰胺合成酶仍然是清除血氨的唯一重要酶。高氨血症导致脑乳酸/丙酮酸比值增加,脑谷氨酸和脑干ATP减少,与苹果酸-天冬氨酸穿梭的干扰一致。在体外,病理水平的氨也抑制脑α -酮戊二酸脱氢酶复合体,以及较弱的丙酮酸脱氢酶复合体。大鼠脑不能通过增加谷氨酰胺合成酶活性来适应长时间的高氨血症。(摘要删节为400字)